21 – 30 of 84
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
L23 Effects of peripheral (co-)administration of liraglutide and ghrelin in the R6/2 mouse brain function
2016) European Huntington Disease Network conference 2016 In Journal of Neurology, Neurosurgery and Psychiatry 87(Suppl 1). p.98-98(
- Contribution to journal › Published meeting abstract
-
Mark
L24 The effect of ghrelin administration in the R6/2 mouse model of Huntington’s disease
2016) European Huntington Disease Network conference 2016 In Journal of Neurology, Neurosurgery and Psychiatry 87(Suppl 1).(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
Characterization of Gastric Mucosa Biopsies Reveals Alterations in Huntington's Disease.
(
- Contribution to journal › Article
-
Mark
A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.
(
- Contribution to journal › Article
-
Mark
Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models.
(
- Contribution to journal › Article
-
Mark
Analysis of White Adipose Tissue Gene Expression Reveals CREB1 Pathway Altered in Huntington's Disease.
(
- Contribution to journal › Article
- 2014
-
Mark
Inflammatory Markers in Huntington’s Disease Plasma – A Robust NanoLC-MRM-MS Assay Development
(
- Contribution to journal › Article
-
Mark
HTT-lowering reverses Huntington's disease immune dysfunction caused by NF kappa B pathway dysregulation
(
- Contribution to journal › Article
-
Mark
Flt3 ligand does not differentiate between Parkinsonian disorders.
(
- Contribution to journal › Article